SC
GILD icon

Slow Capital’s Gilead Sciences GILD Stock Holding History

Slow Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,728
Closed -$343K – 156
2021
Q4 		$343K Sell
4,728
-146
-3% -$10.1K 0.06% 150
2021
Q3 		$340K Buy
4,874
+298
+7% +$20.9K 0.06% 155
2021
Q2 		$315K Buy
4,576
+200
+5% +$13.4K 0.06% 149
2021
Q1 		$283K Buy
4,376
+706
+19% +$45.5K 0.06% 156
2020
Q4 		$214K Buy
3,670
+617
+20% +$37.2K 0.05% 171
2020
Q3 		$193K Buy
+3,053
New +$212K 0.05% 168
2018
Q2 		– Sell
-600
Closed -$45K – 160
2018
Q1 		$45K Hold
600
– – 0.02% 167
2017
Q4 		$43K Buy
+600
New +$45.6K 0.02% 155

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Slow Capital's GILD Position: Q1 2022 in Review

Slow Capital sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 4,728 shares — an estimated $343K sold.

Slow Capital first reported a position in GILD in Q4 2017 and held it in 8 quarters. The position peaked at $343K in Q4 2021. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Slow Capital reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • Slow Capital sold 4,728 Gilead Sciences shares in Q1 2022, an estimated $343K.
  • Slow Capital first reported a position in Gilead Sciences in Q4 2017 and held it in 8 quarters.
  • Slow Capital's Gilead Sciences position peaked at $343K in Q4 2021.
  • 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Slow Capital's 13F filing for Q1 2022, filed 2 May 2022.